Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Nature Chemical Biology
|
August 24, 2023
Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5
Laura A Hehl, Daniel Horn-Ghetko, J Rajan Prabu, et al.
BMC Public Health
|
August 27, 2005
Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China
Don C Des Jarlais, Patrick Johnston, Patricia Friedmann, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitors
F G Salituro, C T Baker, J J Court, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
February 25, 2015
Effects of rare-earth size on the electronic structure of La1−xLuxVO3
B Chen, J Laverock, D Newby, et al.
Nature Structural & Molecular Biology
|
April 11, 2024
Noncanonical assembly, neddylation and chimeric cullin-RING/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex
Daniel Horn-Ghetko, Linus V M Hopf, Ishita Tripathi-Giesgen, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
July 1, 1995
Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506
D M Armistead, M C Badia, D D Deininger, et al.
Molecular Cell
|
December 19, 2023
Multisite phosphorylation dictates selective E2-E3 pairing as revealed by Ubc8/UBE2H-GID/CTLH assemblies
Jakub Chrustowicz, Dawafuti Sherpa, Jerry Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization
Robert B Perni, Janos Pitlik, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 1, 2003
Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variants
Robert B Perni, Shawn D Britt, John C Court, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease
Robert B Perni, Susan J Almquist, Randal A Byrn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Nature Chemical Biology
|
August 24, 2023
Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5
Laura A Hehl, Daniel Horn-Ghetko, J Rajan Prabu, et al.
BMC Public Health
|
August 27, 2005
Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China
Don C Des Jarlais, Patrick Johnston, Patricia Friedmann, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitors
F G Salituro, C T Baker, J J Court, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
February 25, 2015
Effects of rare-earth size on the electronic structure of La1−xLuxVO3
B Chen, J Laverock, D Newby, et al.
Nature Structural & Molecular Biology
|
April 11, 2024
Noncanonical assembly, neddylation and chimeric cullin-RING/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex
Daniel Horn-Ghetko, Linus V M Hopf, Ishita Tripathi-Giesgen, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
July 1, 1995
Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506
D M Armistead, M C Badia, D D Deininger, et al.
Molecular Cell
|
December 19, 2023
Multisite phosphorylation dictates selective E2-E3 pairing as revealed by Ubc8/UBE2H-GID/CTLH assemblies
Jakub Chrustowicz, Dawafuti Sherpa, Jerry Li, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization
Robert B Perni, Janos Pitlik, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 1, 2003
Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variants
Robert B Perni, Shawn D Britt, John C Court, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease
Robert B Perni, Susan J Almquist, Randal A Byrn, et al.
Page
of 6